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Abstract
Cranial neural crest cells (CNCCs) have the remarkable capacity to generate both the non-ectomesenchyme derivatives of
the peripheral nervous system and the ectomesenchyme precursors of the vertebrate head skeleton, yet how these
divergent lineages are specified is not well understood. Whereas studies in mouse have indicated that the Twist1
transcription factor is important for ectomesenchyme development, its role and regulation during CNCC lineage decisions
have remained unclear. Here we show that two Twist1 genes play an essential role in promoting ectomesenchyme at the
expense of non-ectomesenchyme gene expression in zebrafish. Twist1 does so by promoting Fgf signaling, as well as
potentially directly activating fli1a expression through a conserved ectomesenchyme-specific enhancer. We also show that
Id2a restricts Twist1 activity to the ectomesenchyme lineage, with Bmp activity preferentially inducing id2a expression in
non-ectomesenchyme precursors. We therefore propose that the ventral migration of CNCCs away from a source of Bmps in
the dorsal ectoderm promotes ectomesenchyme development by relieving Id2a-dependent repression of Twist1 function.
Together our model shows how the integration of Bmp inhibition at its origin and Fgf activation along its migratory route
would confer temporal and spatial specificity to the generation of ectomesenchyme from the neural crest.
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Introduction
The neural crest is a transient, migratory cell population that
arises at the boundary between the neural and non-neural
ectoderm [1]. Although both cranial and trunk neural crest cells
differentiate into non-ectomesenchyme derivatives, such as
neurons, glia and pigment cells, CNCCs also generate ectome-
senchyme derivatives, in particular many of the cartilage-, bone-,
and teeth-forming cells of the head [2]. Whereas much is known
about how individual non-ectomesenchyme lineages are specified,
how the ectomesenchyme lineage is specified remains actively
debated [3]. When the ectomesenchyme versus non-ectomesench-
yme lineage decision is made during CNCC development also
remains unknown. Whereas cultured avian CNCCs can clonally
generate both lineages [2], lineage tracing experiments in zebrafish
embryos have failed to identify a common precursor [4,5].
In zebrafish, CNCCs are first apparent within the anterior neural
plate border at 10.5 hours-post-fertilization (hpf), when they begin
to express sox10, foxd3, sox9b, and tfap2a. Within the next few hours,
three streams of CNCCs can be seen migrating away from the
neural tube to more ventral positions. Starting around 15.5 hpf,
ectomesenchyme precursors begin to downregulate early CNCC
genes such as sox10, foxd3, sox9b, and tfap2a [6,7] and up-regulate
ectomesenchyme-specificgenessuchasdlx2a[8]and fli1a[9]. These
ectomesenchyme cells then go on to populate a series of pharyngeal
arches from which develops the support skeleton of the jaw and gills
in zebrafish, and the jaw, middle ear, and larynx in mammals [10].
Whereas dlx2a and fli1a are uniquely expressed in the ectome-
senchyme lineage, Dlx2a appears to be dispensable for ectome-
senchyme formation [8] and the function of Fli1a in ectomesench-
yme development remains unknown.
One factor critical for ectomesenchyme specification in mouse is
the basic-helix-loop-helix (bHLH) transcription factor Twist1.
Both the conventional Twist1 knockout and a conditional Twist1
neural-crest-specific (Wnt1-CRE) knockout display defective
ectomesenchyme development, including abnormal perdurance
of Sox10 and loss of expression of many arch ectomesenchyme
genes [11,12]. Furthermore, the neural-crest-specific knockout
showed severe reductions of the CNCC-derived craniofacial
skeleton, although the lower jaw was less affected. Zebrafish have
two Twist1 orthologs, with twist1b being expressed in early
CNCCs and twist1a restricted to ectomesenchyme precursors from
16 hpf onwards [13]. Here, we show that these two Twist1 genes
function redundantly for zebrafish ectomesenchyme development,
with Twist1 depletion resulting in both perdurance of sox10 and
loss of fli1a expression.
As Twist1 genes are expressed throughout the early CNCC
domain, an important yet unanswered question is how Twist1
function is specifically regulated in ectomesenchyme precursors.
Twist1 function can be regulated by post-translational modifica-
tion (e.g. phosphorylation), as well as choice of dimerization
partners. In particular, Inhibitor of differentiation (Id) proteins,
which share HLH but not basic DNA-binding domains with
bHLH factors, influence Twist1 homodimer versus heterodimer
formation by sequestering Twist1 binding partners such as E2A
[14,15]. Id genes are widely expressed in the early neural crest,
and Id2 has been shown to promote neural crest at the expense of
epidermis in avians [16]. In zebrafish, Id2a has been shown to
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autonomously, yet its role in CNCC development has not been
explored [17]. In this study we find a novel role of Id2a in CNCC
lineage decisions, with down-regulation of id2a in migrating
CNCCs being essential for ectomesenchyme specification.
Upstream signals that specify ectomesenchyme could originate
from the ectoderm where CNCCs are born, from the mesoderm
along which CNCCs migrate, or from the endoderm/ectoderm
upon which CNCCs condense within the pharyngeal arches.
Previous studies have suggested roles for Fgf signaling, in particular
Fgf20b and Fgfr1, in ectomesenchyme specification in avians and
zebrafish [18,19]. It was further proposed that CNCCs might
acquire ectomesenchyme identity upon arrival in the pharyngeal
arches, potentially as a result of endoderm-secreted Fgfs [18]. In
contrast, lineage-tracing experiments have revealed that CNCCs in
zebrafish are largely restricted to single lineages before migration
[4,5], suggesting that ectomesenchyme fates may be specified at
their birthplace within the neural plate border ectoderm.
Bmps such as bmp2b in zebrafish are prominently expressed in
the non-neural ectoderm, where they influence neural crest
induction, migration, survival, and differentiation [20,21,22]. How-
ever, a role for Bmp signaling in ectomesenchyme lineage decisions
has not been previously described, likely because of the earlier
essential roles of Bmps in neural crest induction [21]. By
manipulating Bmp signaling specifically in migratory CNCCs, we
have uncovered an additional function of Bmp signaling inrestricting
ectomesenchyme potential, in part by maintaining high levelsof Id2a.
We therefore propose a model in which the early migration of
CNCCs away from an ectodermal Bmp source results in down-
regulation of Bmp activity and id2a expression, which in turn
promotes Twist1-dependent establishment of ectomesenchyme fates.
Results
Twist1a and Twist1b are redundantly required for
ectomesenchyme specification in zebrafish
In order to test whether Twist1 genes are required for
ectomesenchyme development in zebrafish, we designed transla-
tion-blocking MOs to deplete both zebrafish Twist1 orthologs -
Twist1a and Twist1b. Injection of twist1a-MO or twist1b-MO alone
resulted in only very subtle changes in sox10 and no changes in
fli1a:GFP transgene expression (Figure S1). In contrast, embryos
injected with both MOs (twist1a/1b-MO) displayed abnormal
persistence of sox10 and reduced expression of fli1a in arch CNCCs
at 18 and 24 hpf, respectively (Figure 1A, 1B, 1E, 1F). Analysis of
doubly transgenic sox10:dsRed; fli1a:GFP embryos injected with
twist1a/1b-MO confirmed that CNCCsstill formed archesof largely
normal size at 28 hpf in the absence of Twist1 function yet failed to
initiate fli1a:GFP expression (Figure S1). Furthermore, arch
expression of dlx2a was relatively unaffected in 18 hpf twist1a/1b-
MO embryos (Figure 1I, 1J). Consistent with the earlier
ectomesenchyme gene expression defects, we also found that
depletion of both Twist1 proteins resulted in severe reductions of
the ectomesenchyme-derived skeleton of the face and anterior
neurocranium at 5 days-post-fertilization (dpf) (Figure 1M, 1N).
Single depletion of either Twist1a or Twist1b resulted in milder
craniofacial defects, particularly in the ventral mandibular and
hyoid cartilages (Figure S1). Importantly, injection of a twist1b
mRNA not targeted by the MOs, but not a control kikGR mRNA,
partially rescued skeletal defects in twist1a/1b-MO embryos, thus
showing specificity of MO-generated defects for Twist1 (Figure S1).
Hence,despitedifferencesintimingoftheirexpression,Twist1aand
Twist1b function redundantly for ectomesenchyme development.
Twist1 function is required in migratory CNCCs for
ectomesenchyme specification
We next investigated whether Twist1 functions in CNCCs for
ectomesenchyme formation. To do so, we developed a transgenic
strategy to misexpress a dominant-negative Twist1b protein
specifically in migratory CNCCs. Caenorhabditis elegans has a single
Twist gene, hlh8, which is required for mesodermal patterning and
vulval muscle development [23]. Mutation of Glutamine 29 to
Lysine in the DNA-binding domain of Hlh8 has been shown to
dominantly interfere with its function [24]. As this residue is
conserved in zebrafish Twist1 genes (Glutamine 84 in Twist1b), we
reasoned that the equivalent mutation might also result in a
dominant-negative protein. We therefore constructed a transgenic
line in which Twist1b-E84K (referred to as dnTwist1b) was
expressed under the Gal4VP16-sensitive UAS promoter. We also
constructed a second transgenic line in which the Gal4VP16
transcriptional activator was expressed under the control of a sox10
neural crest promoter [25]. Although the endogenous sox10 gene is
first expressed in pre-migratory CNCCs at 10.5 hpf, in situ
hybridizations for kikGR mRNA in sox10:Gal4VP16; UAS:kikGR
embryos revealed transgene expression within migratory CNCCs
at 13 hpf, but not earlier within premigratory CNCCs at 11 hpf
(Figure S2). Hence, this sox10:Gal4VP16 line allows us to alter
genetic pathways specifically in migratory CNCCs. Consistent
with a requirement for Twist1 in migratory CNCCs, we observed
persistent sox10 and reduced fli1a expression in the arches of
sox10:Gal4VP16; UAS:dnTwist1b embryos, similar to what we
observed in twist1a/1b-MO embryos (Figure 1). We also observed
a partial reduction of arch dlx2a expression upon dnTwist1b
misexpression, as well as reductions of the facial skeleton,
particularly in the jaw region (Figure 1K, 1L, 1O, 1P). Hence,
the similar phenotypes of twist1a/1b-MO embryos and transgenic
embryos with CNCC-specific disruption of Twist1 function
indicate that zebrafish Twist1 genes function largely in migratory
CNCCs for ectomesenchyme development.
Twist1 genes globally activate ectomesenchyme and
inhibit non-ectomesenchyme gene expression
Twist1 could regulate the transition from early multipotent
CNCCs to ectomesenchyme precursors, or alternatively fate
Author Summary
A fascinating question of vertebrate development is how a
single cell population—the cranial neural crest—creates
such different types of structures as the peripheral nervous
system and head skeleton. To date, the molecular signals
that instruct neural crest cells to develop into head
skeleton at the expense of nervous system have remained
elusive. One reason why such signals have been difficult to
identify is that they may be required at multiple stages of
development—such as in the emergence of neural crest
cells themselves. In order to overcome this challenge, we
developed a transgenic system in zebrafish that allows us
to alter signaling precisely at the stage when neural crest
cell fates are determined. In so doing, we have found that
the early movement of neural crest cells allows them to
escape the influence of suppressive signals at their
birthplace, which, in turn, sets in motion a cascade that
turns off nervous system genes and turns on head skeleton
genes. Together, our studies show how the timing of
neural crest cell movement plays a major role in biasing
early neural crest cells to form the head skeleton.
Bmps Inhibit Ectomesenchyme
PLoS Genetics | www.plosgenetics.org 2 May 2012 | Volume 8 | Issue 5 | e1002710Figure 1. Twist1 genes are required for ectomesenchyme specification in zebrafish. (A–D) Whole mount in situ hybridizations of sox10
expression at 18 hpf show ectopic expression in the arches (numbered and second arch indicated by black arrow) of twist1a/1b-MO (n=16/16) and
sox10:Gal4VP16; UAS:dnTwist1b (n=4/4) embryos compared to un-injected (n=0/14) and sox10:Gal4VP16 only (n=0/9) controls. White arrowheads
indicate otic expression. (E–H) Whole mount in situs at 24 hpf show reduction of fli1a expression in the arch ectomesenchyme (numbered) of twist1a/
1b-MO (n=12/12) and sox10:Gal4VP16; UAS:dnTwist1b (n=5/5) embryos compared to un-injected (n=0/13) and sox10:Gal4VP16 only (n=0/8)
controls. Insets in E and F highlight arch ectomesenchyme which is reduced in twist1a/1b-MO embryos. Vascular expression of fli1a (red arrowheads)
is unaffected. (I–L) Whole mount in situs at 18 hpf show a slight reduction of dlx2a in sox10:Gal4VP16; UAS:dnTwist1b embryos (n=4/4) but not un-
injected (n=0/6), twist1a/1b-MO (n=0/8), and sox10:Gal4VP16 only (n=0/6) embryos. (M-P) Skeletal staining at 5 dpf shows severe loss of CNCC-
derived head skeleton in twist1a/1b-MO embryos (n=21/21) and primarily jaw reductions in sox10:Gal4VP16; UAS:dnTwist1b embryos (n=9/9)
compared to no defects in un-injected (n=0/24) and sox10:Gal4VP16 only (n=0/16) controls. Whereas only small remnants remain of the CNCC-
derived skeleton (arrows), the mesoderm-derived otic capsule cartilage (arrowheads) and posterior neurocranium are less affected in twist1a/1b-MO
embryos. (Q–T) In situs for dct expression at 28 hpf show normal melanophore precursors in un-injected (n=14), twist1a/1b-MO (n=12),
sox10:Gal4VP16 only (n=8), and sox10:Gal4VP16; UAS:dnTwist1b (n=8) embryos. (U–X) In situs for xdh expression at 28 hpf show normal
xanthophore precursors in un-injected (n=7), twist1a/1b-MO (n=5), sox10:Gal4VP16 only (n=9), and sox10:Gal4VP16; UAS:dnTwist1b (n=8) embryos.
(Y-AB) In situs for foxd3 expression at 48 hpf reveal largely normal patterns of glia in un-injected (n=9), twist1a/1b-MO (n=8), sox10:Gal4VP16 only
(n=9), and sox10:Gal4VP16; UAS:dnTwist1b (n=8) embryos. Scale bar=50 mm.
doi:10.1371/journal.pgen.1002710.g001
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lineages. In order to examine these possibilities without bias, we
performed microarray-based gene expression profiling of purified
sox10:GFP-positive CNCCs from 18 hpf un-injected or twist1a/1b-
MO-injected embryos (Figure 2A, 2B). We next compared the
relative enrichment of transcripts in GFP-positive versus GFP-
negative CNCCs of un-injected and twist1a/1b-MO embryos to
identify CNCC-specific genes up or down regulated by Twist1
depletion (Figure 2C). By comparing the GFP+/GFP2 ratio
between un-injected and twist1a/1b-MO embryos (as opposed to
simply comparing expression levels between GFP+ fractions), we
controlled for possible non-specific effects of MO toxicity on gene
expression (i.e. non-specific toxicity is predicted to equally affect
GFP+ and GFP2 fractions and thus toxicity effects would cancel
out in the ratio). By analyzing data sets with respect to published
gene expression patterns (Table S1), we found that the down-
regulated set included many known ectomesenchyme genes (e.g.
lama4, grem2, loxl2a, pcdh18a, and fli1a) and the up-regulated set
included genes expressed in non-ectomesenchyme lineages such as
neurons (e.g. nr4a2b, atpa1a1, and aacs), glia (e.g. rab3ip), and
pigment (e.g. gch2 and ednrb1) (Figure 2C). In order to validate
several of the most differentially expressed genes, we next
performed in situ hybridization. Whereas the ectomesenchyme
expression of fli1a was severely reduced (Figure 1F), the non-
ectomesenchyme expression domains of nr4a2b and gch2 were
increased in intensity and expanded in size in twist1a/1b-MO
embryos at 18 hpf (Figure 2D–2G). However, unlike sox10, nr4a2b
and gch2 were not ectopically expressed in Twist1-depleted arches.
As expected, sox10 was also upregulated 1.28 fold. This modest
upregulation is likely due to the more widespread expression of
sox10 in non-ectomesenchyme and trunk neural crest cells not
affected by loss of Twist1 function, thus diluting the effect of the
specific ectomesenchyme upregulation when total neural crest
fractions are analyzed. This limitation indicates that other genes
that behave like sox10 may have been overlooked in our analysis.
Although early CNCC genes did not appear as top hits in our
microarray analysis, sox10 expression did abnormally persist in
twist1a/1b-MO ectomesenchyme (Figure 2I). We therefore asked
whether this was a general property of genes expressed in the early
CNCC domain. sox10, sox9b, tfap2a, and foxd3 are expressed in
wild-type CNCCs beginning around 10.5 hpf but not in arch
ectomesenchyme at 24 hpf. In Twist1-depleted embryos, we
Figure 2. Gene expression profiling in twist1a/1b-MO embryos. (A,B) sox10:GFP-positive and -negative cells were isolated from un-injected or
twist1a/1b-MO embryos at 18 hpf by FACS. (C) Fold changes of the GFP+/GFP2 ratios between twist1a/1b-MO and un-injected controls show the top
25 up-regulated (blue) and down-regulated (red) genes after Twist1 depletion. Color codes indicate where genes are expressed based on the
published literature (see Table S1 for references). (D–O) Confocal projections of fluorescent in situ hybridizations show expanded expression of gch2
and nr4a2b at 18 hpf, ectopic arch expression (arrows) of sox10 and foxd3 at 24 hpf, but no change in sox9b and tfap2a expression at 24 hpf in
twist1a/1b-MO versus un-injected controls. Scale bar=50 mm.
doi:10.1371/journal.pgen.1002710.g002
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(Figure 2J–2O). Whereas several studies have established roles for
Sox10 and Foxd3 in maintaining neural crest multipotency [26],
these transcription factors also have later roles in promoting non-
ectomesenchyme lineages such as melanocytes, neurons, and glia
[27,28]. The lack of sox9b and tfap2a upregulation in twist1a/1b-
MO embryos argues against a general perdurance of early CNCC
expression, with the ectopic expression of sox10 and foxd3 likely
reflecting the upregulation of non-ectomesenchyme gene expres-
sion observed in our microarray analysis. However, despite the
ectopic expression of sox10 and foxd3 in 24 hpf twist1a/1b-MO
arches, we failed to observe ectopic foxd3-positive glia, HuC/D-
positive cranial ganglionic neurons, dct-positive melanophores, or
xdh-positive xanthophores in the arches of either twist1a/1b-MO or
sox10:Gal4VP16; UAS:dnTwist1b larvae at later stages (Figure 1Q–
1AB and Figure S3). Instead, the sox10:GFP-positive arches of
twist1a/1b-MO embryos were reduced at 36 hpf, and even more so
at 48 hpf, with Lysotracker staining revealing increased cell death
in arch CNCCs and putative CNCCs in the dorsal neural tube
(Figure S4 and data not shown). In addition, expression of the
early chondrocyte marker sox9a was very reduced in arch CNCCs
of 48 hpf twist1a/1b-MO embryos (Figure S4G) yet was less
affected in the mesoderm-derived precursors of the otic capsule
cartilage which is less sensitive to loss of Twist1a/1b function
(Figure 1N). Hence, arch CNCCs undergo cell death and fail to
initiate skeletal gene expression in the absence of Twist1 function
yet do not form ectopic non-ectomesenchyme derivatives.
Twist1 is required for Fgf signaling in ectomesenchyme
precursors
As Fgf signaling has also been shown to promote ectomesench-
yme fates [18,19], we next examined whether Twist1 might be
required for Fgf signaling during ectomesenchyme development.
In zebrafish embryos, pea3 expression is entirely dependent on Fgf
signaling [29], and we observed decreased pea3 expression in the
arches of twist1a/1b-MO embryos at 18 hpf (Figure 3B), consistent
with Twist1 being required for Fgf signaling in migrating CNCCs.
We next investigated to what extent loss of Fgf signaling accounts
for the ectomesenchyme gene expression defects seen upon Twist1
depletion. To do so, we inhibited Fgf signaling specifically in
migratory CNCCs through transgenic misexpression of a domi-
nant-negative version of Fgfr1a (dnFgfr1a). In sox10:Gal4VP16;
UAS:dnFgfr1a embryos, we observed persistent sox10 and reduced
dlx2a expression in the arches, yet, unlike Twist1-deficient
embryos, fli1a expression was largely unaffected (Figure 3C–3H).
This effect of Fgf inhibition on ectomesenchyme formation was
not due to transcriptional regulation of Twist1 genes as both
twist1a and twist1b were expressed normally in 24 hpf sox10:-
Gal4VP16; UAS:dnFgfr1a embryos (Figure 3I–3L). We therefore
conclude that Fgf signaling likely functions downstream of Twist1
to repress sox10 and activate dlx2a expression yet plays less of a role
in fli1a expression.
Twist1 regulates fli1a expression through an
ectomesenchyme-specific enhancer
As we determined that Fgf signaling is not required for fli1a
ectomesenchyme expression, we next examined whether Twist1
might more directly activate fli1a expression. We first used a
comparative genomics and transient transgenic approach to
identify ectomesenchyme-specific regulatory regions of the fli1a
gene. A ,15 kb region centered around the first exon of the fli1a
gene had previously been shown to drive expression in both the
ectomesenchyme and vasculature [30], and we used the mVISTA
program [31] to identify seven short (,500 bp) sub-regions (A–H)
that were conserved between zebrafish, puffer fishes (Takifugu
rubripes and Tetraodon nigroviridis), stickleback (Gasterosteus aculeatus),
and medaka (Oryzias latipes). By testing the ability of these sub-
regions to drive GFP expression in conjunction with the hsp70I
core promoter, we identified two vasculature-specific enhancers (G
and H) and one ectomesenchyme-specific enhancer (F) (Figure 4A).
Element F, located ,1.5 kb upstream of the fli1a promoter, was
sufficient to drive GFP expression in the ectomesenchyme from 19
hpf onwards, as confirmed by co-localization with a sox10:dsRed
Figure 3. Fgf signaling depends on Twist1 and regulates a
subset of ectomesenchyme gene expression. (A,B) In situs at 18
hpf show that expression of the Fgf target gene pea3 is reduced in the
arches (numbered) of twist1a/1b-MO embryos (n=8/8) compared to un-
injected controls (n=0/12). (C–L) sox10:Gal4VP16; UAS:dnFgfr1a embry-
os show ectopic arch expression of sox10 at 18 hpf (n=8/8) versus
controls (n=0/8), reduction of dlx2a at 24 hpf (n=3/3) versus controls
(n=0/3), but no change in fli1a at 24 hpf (n=0/7) versus controls (n=0/
5). twist1a expression was unchanged at 24 hpf in dnFgfr1a embryos
(n=10) compared to controls (n=7), as was twist1b expression in
dnFgfr1a embryos (n=8) compared to controls (n=8). Black arrows
indicate the second arch, white arrowheads the ear, and red
arrowheads the vasculature. Scale bar=50 mm.
doi:10.1371/journal.pgen.1002710.g003
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enhancer F ,1.7 kb upstream of the mouse Fli1 gene, with both
the mouse and fish Fli1 genes containing a perfectly conserved
element, CAGATG, that matches the bHLH binding site,
CANNTG (though Twist1 most strongly prefers CATATG) [32]
(Figure 4B). This putative Twist1 binding site was required for
enhancer function, as mutation to GTATAC abolished the ability
of the fli1a element F enhancer to direct ectomesenchyme
expression in zebrafish embryos and to potentiate Twist1-
dependent transgene expression in mammalian 293T cells
(Figure 3D, 3G). Twist1 was also required for enhancer F activity
as injection of twist1a/1b-MO prevented ectomesenchyme expres-
sion in a stable Tg(fli1a-F-hsp70I:GFP) transgenic line, though this
effect could equally likely be indirect (Figure 4E, 4F). Together,
our results are consistent with Twist1 activating fli1a expression
through a conserved enhancer element.
Exclusion of id2a expression is necessary for
ectomesenchyme specification
As Twist1 genes are expressed throughout the early CNCC
domain (e.g. twist1b in zebrafish), we next examined whether
dimerization partners might regulate the ectomesenchyme-specific
function of Twist1. The Id class of proteins modulates Twist1
function by preventing the formation of Twist1-class B heterodi-
mers [14,15], and several Id family members are expressed in early
CNCCs [33,34,35]. Intriguingly, we found that zebrafish id2a was
broadly co-expressed with sox10 in early CNCCs (12 and 14 hpf)
yet by 16.5 hpf was restricted to sox10-positive non-ectomesench-
yme and excluded from ectomesenchyme expressing dlx2a and
twist1a (Figure 5). As the down-regulation of id2a expression tightly
correlates with ectomesenchyme specification, we next investigated
whether the exclusion of Id2a from ectomesenchyme precursors
was required for their differentiation. Indeed, when Id2a was
misexpressed throughout migratory CNCCs in sox10:Gal4VP16;
UAS:Id2a embryos, we observed persistent expression of sox10 and
reduced expression of fli1a in arch CNCCs, as well as mild
reductions of dlx2a expression (Figure 6A–6F). The effect of Id2a
misexpression was specific to the ectomesenchyme, as we observed
severe reductions of the craniofacial skeleton but no defects in the
non-ectomesenchyme-derived melanophore and xanthophore
precursors (Figure 6G–6L) and HuC/D-positive cranial ganglionic
neurons (Figure S3). However, we note that the sox10 promoter
also drives later expression in chondrocytes [36], and thus we
cannot rule out that the skeletal defects of sox10:Gal4VP16;
UAS:Id2a animals are additionally or alternatively due to this later
phase of Id2a misexpression. In any event, the ectomesenchyme
Figure 4. Twist1 regulates fli1a expression through an ectomesenchyme-specific enhancer. (A) Schematic shows the fli1a genomic locus
with hatch marks at 1 kb intervals. Predicted enhancers (grey boxes, ‘‘A–H’’) and the first exon (red box) are shown. Below are the various enhancer
constructs analyzed, with the hsp70I core promoter in blue and GFP in green. Wild-type (black) and mutant (red) versions of the putative Twist1
binding site are also shown, as is the percentage of transient transgenic embryos showing GFP expression in the pharyngeal arches or vasculature. (B)
Alignment of the central portion of the F enhancer between five fish species and mouse. The putative bHLH/Twist1 binding site is boxed in red. (C,D)
Confocal projections of 32 hpf sox10:dsRed embryos injected at the one-cell-stage with fli1a-F enhancer constructs. The wild-type (C) but not mutant
(D) enhancer drives arch expression. (E and F) Confocal sections of merged GFP and DIC channels show that a stable Tg(fli1a-F-hsp70I:GFP) line
displays arch GFP expression in 32 hpf wild-type (E) but not twist1a/1b-MO (F) embryos. (G) Luciferase activity relative to renilla firefly activity in 293T
cells transfected with wild-type or mutant fli1a-F enhancer reporter constructs, with or without a Twist1 expression plasmid. Asterisks indicate
significant comparisons using a student’s t-test (p,0.05). Arbitrary units and standard error of the mean are shown.
doi:10.1371/journal.pgen.1002710.g004
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that Id2a does not generally inhibit CNCC differentiation but
instead specifically restricts ectomesenchyme fates. Furthermore,
the highly similar defects seen upon Id2a misexpression and
depletion of Twist1 are consistent with Id2a functioning to inhibit
Twist1 in CNCCs. However, this inhibition of Twist1 function by
Id2a is likely at the protein and not transcriptional level as twist1a
and twist1b expression were unaffected by Id2a misexpression
(Figure 6M–6P).
Bmp signaling regulates id2a expression in non-
ectomesenchyme CNCCs
We next investigated the mechanism by which id2a expression
becomes restricted to non-ectomesenchyme precursors. Bmps are
Figure 5. id2a is regulated by Bmps and excluded from the ectomesenchyme. (A–C) Colorimetric in situs show weak expression of id2a in
pre-migratory CNCCs at 12 hpf (dorsal view with anterior up, arrows indicate bilateral CNCC fields) and increasing expression in non-
ectomesenchyme precursors at 17.5 and 19 hpf (lateral views). (D–I) Confocal projections of fluorescent in situs show co-localization of id2a with
sox10 in CNCCs at 12 hpf (D) and 14 hpf (E), as well as co-localization in the non-ectomesenchyme at 16.5 hpf (F). At 16.5 hpf, id2a is excluded from
ectomesenchyme CNCCs marked by dlx2a (G) and twist1a (H), with twist1a also being expressed in head mesoderm. In sox10:Gal4VP16; UAS:Bmp4
embryos, id2a and sox10 are expressed ectopically in the ectomesenchyme (white arrows). Arrowheads indicate otic expression of sox10. Scale
bars=50 mm.
doi:10.1371/journal.pgen.1002710.g005
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that CNCC-specific misexpression of Bmp4 in sox10:Gal4VP16;
UAS:Bmp4 embryos resulted in ectopic expression of id2a in arch
ectomesenchyme (Figure 5I). To analyze whether down-regulation
of Bmp activity also coincides with loss of id2a expression in wild-
type ectomesenchyme precursors, we performed immunostaining
for the phosphorylated form of Smad1/5/8 (pSmad1/5/8), which
is thought to broadly indicate canonical Bmp activity [38].
Consistent with the known role of Bmps in neural crest induction
[39], all CNCCs displayed high levels of pSmad1/5/8 at pre-
migratory stages (12 hpf) (Figure 7A). In contrast, ectomesenchyme
precursors down-regulated pSmad1/5/8 by 16.5 hpf, while more
dorsal non-ectomesenchyme precursors continued to display high
pSmad1/5/8 (Figure 7B,7C). Cross-sectional views demonstrated
that ventral CNCCs with low pSmad1/5/8 were located deep to
the ectoderm whereas dorsal CNCCs with high pSmad1/5/8 had
yet to delaminate and remained in the neural plate ectoderm
(Figure 7D).
Bmp4 misexpression inhibits ectomesenchyme
specification
We next examined whether the observed down-regulation of
Bmp activity in ectomesenchyme precursors was necessary for
their formation. Strikingly, Bmp4 misexpression in migratory
CNCCs of sox10:Gal4VP16; UAS:Bmp4 embryos resulted in
profound defects in ectomesenchyme specification, including
persistent sox10 expression and reduced expression of fli1a and
dlx2a (Figure 8A–8H). Importantly, the reduction of fli1a and dlx2a
arch expression was not simply due to a lack of CNCC formation,
migration, or survival. The examination of sox10-positive CNCCs
in 15 hpf Bmp4-misexpression embryos revealed no major defects
in CNCC induction or migration (Figure S5), and Lysotracker
staining also revealed no major increases in CNCC apoptosis
(Figure S6). Moreover, although fewer CNCCs were found in the
arches of Bmp4-misexpression embryos at later stages (as shown by
lineage tracing using the mKR red fluorescent protein at 24 hpf),
those CNCCs found in the arches also displayed reduced fli1a and
dlx2a expression (Figure 8E–8H). As with Twist1 depletion or Id2a
misexpression, Bmp4 misexpression also resulted in specific
reductions of the ectomesenchyme-derived craniofacial skeleton
without affecting the non-ectomesenchyme-derived foxd3-positive
glia, dct-positive melanophores, and xdh-positive xanthophores
(Figure 8I–8P).
The ectoderm is a likely source of Bmps for
ectomesenchyme specification
We also investigated which tissue is the likely source of Bmps for
the ectomesenchyme lineage decision. A previous study had
Figure 6. Forced expression of Id2a in CNCCs inhibits ectomesenchyme specification. (A–F) Whole mount in situs show ectopic arch
expression of sox10 at 18 hpf in sox10:Gal4VP16; UAS:Id2a embryos (n=7/7) but not sox10:Gal4VP16 only controls (n=0/9), loss of fli1a arch
expression at 24 hpf in sox10:Gal4VP16; UAS:Id2a embryos (n=4/4) but not sox10:Gal4VP16 only controls (n=0/17), and mild reductions of dlx2a arch
expression at 18 hpf in sox10:Gal4VP16; UAS:Id2a embryos (n=5/5) but not sox10:Gal4VP16 only controls (n=0/8). Arches are numbered. Arrows
denote the second arch, white arrowheads the developing ear, and red arrowheads the vasculature. (G and H) Skeletal staining at 5 dpf shows severe
reduction of the craniofacial skeleton in sox10:Gal4VP16; UAS:Id2a embryos (n=17/17) compared to sox10:Gal4VP16 only controls (n=0/22). (I and J)
In situs for dct expression at 28 hpf show that melanophore precursors are unaffected in sox10:Gal4VP16; UAS:Id2a embryos (n=8) and
sox10:Gal4VP16 only controls (n=8). (K and L) In situs for xdh expression at 28 hpf show that xanthophore precursors are unaffected in
sox10:Gal4VP16; UAS:Id2a embryos (n=4) and sox10:Gal4VP16 only controls (n=4). (M–P) twist1a expression at 18 hpf is unaffected in
sox10:Gal4VP16; UAS:Id2a embryos (n=12) versus sox10:Gal4VP16 only controls (n=11). twist1b expression at 18 hpf is similarly unaffected in
sox10:Gal4VP16; UAS:Id2a embryos (n=7) versus sox10:Gal4VP16 controls (n=8). Id2a misexpression embryos are to the right in I–P. Scale
bars=50 mm.
doi:10.1371/journal.pgen.1002710.g006
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mRNA encoding the Nodal antagonist Antivin, resulted in severe
reductions of dlx2a-positive ectomesenchyme at 24 hpf [40], yet it
was unclear whether the loss of dlx2a reflected defects in the
specification or later endoderm-mediated survival of ectomesench-
yme precursors [41,42,43,44]. By performing similar Antivin
mRNA injections, we found normal dlx2a and fli1a induction at
15.5 hpf and sox10 down-regulation by 19 hpf in the presumptive
ectomesenchyme of embryos lacking endoderm and mesoderm
(Figure 9). Hence, rather than signals deriving from the arch
endoderm and/or mesoderm [18], our data are more consistent
with signals from the non-neural ectoderm, such as Bmps,
influencing ectomesenchyme fates.
Id2a is required for Bmps to inhibit ectomesenchyme
formation
As Id2a and Bmp4 misexpression resulted in similar ectome-
senchyme defects, we next examined whether Id2a might mediate
the negative effects of Bmps on ectomesenchyme development. To
do so, we injected a previously validated translation-blocking id2a-
MO [17] into one-cell-stage embryos to deplete Id2a protein.
Whereas injection of id2a-MO caused no ectomesenchyme defects
on its own, injection into sox10:Gal4VP16; UAS:Bmp4 embryos
fully rescued persistent sox10 and reduced dlx2a arch expression, as
well as partially rescuing fli1a arch expression (Figure 10). In
contrast, injection of twist1b mRNA failed to rescue sox10
persistence in sox10:Gal4VP16; UAS:Bmp4 embryos (Figure S7).
Together, these results support a model in which, rather than
inhibiting twist1a or twist1b at the transcriptional level, Bmps
negatively regulate Twist1 ectomesenchyme function through
induction of the Id2a negative regulator.
Discussion
Here we present evidence for a new model of ectomesenchyme
formation. Upon delamination from the neural plate border, early
migrating CNCCs downregulate Bmp activity and id2a expression,
thus allowing activation of Twist1. Twist1 then promotes
ectomesenchyme and inhibits non-ectomesenchyme gene expres-
sion through both potentiation of Fgf signaling and activation of
genes such as fli1a (Figure 11). A salient feature of our model is that
the integration of Bmp inhibition at their origin and Fgf activation
along their migratory route would confer temporal and spatial
specificity to the generation of ectomesenchyme fates from
CNCCs.
Twist1 promotes ectomesenchyme at the expense of
non-ectomesenchyme gene expression
The CNCC-derived craniofacial skeleton is nearly completely
lost in zebrafish with reduced Twist1a and Twist1b function. This
loss of skeleton does not appear to be due to defects in the
generation or migration of CNCCs as shown by the presence of
largely normal numbers of migrating dlx2a-positive CNCCs at 18
hpf and sox10:dsRed-positive arch CNCCs at 28 hpf in twist1a/1b-
MO embryos. Instead, we found that Twist1a and Twist1b are
redundantly required for a subset of ectomesenchyme gene
expression, in particular the early induction of fli1a and inhibition
of sox10, with the later severe loss of facial skeleton precisely
correlating with a loss of pre-chondrogenic sox9a expression, as
well as increased cell death in the arches. However, dlx2a
expression was much less affected in twist1a/1b-MO embryos, as
well as in mice with CNCC-specific deletion of Twist1, suggesting
that some aspects of ectomesenchyme formation may be Twist1-
independent [11]. Our data in zebrafish are generally in
agreement with previous studies of Twist1 function in mouse.
Conventional Twist1
2/2 mutant mice also displayed arch
persistence of Sox10 and loss of later Sox9 expression, although
Fli1 and early Dlx2 expression were not examined and lethality at
E10.5–E11.5 precluded an analysis of the extent of craniofacial
skeletal loss [12]. In addition, Twist1 function was required largely
in CNCCs for Sox10 repression and craniofacial skeleton
development in both zebrafish (this study) and mouse [11],
although in both species the facial skeleton was not as affected as in
twist1a/1b-MO zebrafish. These phenotypic differences might
reflect incomplete efficacy of the dnTwist1b transgene at reducing
endogenous Twist1 function, or alternatively additional non-
Figure 7. Bmp activity is selectively down-regulated in ectomesenchyme precursors. (A) Confocal projection of pSMAD1/5/8
immunostaining at 12 hpf shows that all sox10:GFP-positive CNCCs display high pSMAD1/5/8. (B–D) At 16.5 hpf, a projection (B) and a high-
magnification section (C, boxed area in B) show that pSMAD1/5/8 remains high in the dorsal non-ectomesenchyme but is lower in the more ventral
ectomesenchyme. An orthogonal section (D, taken at the level of the line in C) shows that high pSMAD1/5/8 CNCCs remain in the neural epithelium
whereas low pSMAD1/5/8 CNCCs are positioned more medial and ventral. The eye also displays high pSMAD1/5/8. Abbreviations: D, dorsal; V, ventral;
A, anterior; P, posterior; M, medial; L, lateral; m, mandibular arch ectomesenchyme; h, hyoid arch ectomesenchyme; n, non-ectomesenchyme; e,
ectomesenchyme; ve, ventral epithelium. Scale bar=50 mm.
doi:10.1371/journal.pgen.1002710.g007
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lost in twist1a/1b-MO larvae) in the migration, survival, and/or
differentiation of arch CNCCs. Indeed, a role for mesodermal
Twist1 in the migration of CNCCs has been inferred from studies
in mouse, although we did not observe major defects in CNCC
migration in twist1a/1b-MO zebrafish.
In theory, Twist1 could promote the transition from a
multipotent CNCC precursor to a more lineage-restricted
ectomesenchyme cell, or alternatively influence fate choices
between ectomesenchyme and non-ectomesenchyme lineages.
However, the observation that only a subset of early CNCC
genes persisted in twist1a/1b-MO arches, combined with the
normal development of CNCC-derived cranial pigment and glial
cells, suggest that CNCCs do not remain as multipotent precursors
in the absence of Twist1 function. Instead, the ectopic arch
expression of sox10 and foxd3 in Twist1-depleted embryos, at a
stage when these genes are normally co-expressed in the non-
ectomesenchyme, suggests that presumptive ectomesenchyme
precursors partially adopt a non-ectomesenchyme expression
profile in the absence of Twist1. This conclusion was confirmed
by our microarray analysis in which non-ectomesenchyme but not
early CNCC genes were the most upregulated in Twist1-deficient
embryos. Unexpectedly, some non-ectomesenchyme genes, such
as nr4a2b and gch2, were upregulated in the non-ectomesenchyme
domain but not ectopically expressed in Twist1-deficient arches,
suggesting that Twist1 may have additional roles in restricting
non-ectomesenchyme gene expression within the early non-
ectomesenchyme domain. Consistent with only a subset of non-
Figure 8. Misexpression of Bmp4 in migrating CNCCs inhibits ectomesenchyme formation. (A–D) Whole mount in situs at 18 hpf show
ectopic expression of sox10 in the arches (numbered) of sox10:Gal4VP16; UAS:Bmp4; UAS:mKR embryos (n=8/8) compared to sox10:Gal4VP16;
UAS:mKR controls (n=0/8) and reductions of dlx2a in sox10:Gal4VP16; UAS:Bmp4; UAS:mKR embryos (n=4/4) compared to sox10:Gal4VP16; UAS:mKR
controls (n=0/4). Arrows indicate the second arch and white arrowheads the developing ear. (E–H) Double fluorescent in situs for mKR (red) and fli1a
or dlx2a (green) at 24 hpf show reduction of fli1a arch expression in sox10:Gal4VP16; UAS:Bmp4; UAS:mKR embryos (n=5/5) compared to
sox10:Gal4VP16; UAS:mKR controls (n=0/9) and reduction of dlx2a arch expression in sox10:Gal4VP16; UAS:Bmp4; UAS:mKR embryos (n=4/4)
compared to sox10:Gal4VP16; UAS:mKR controls (n=0/3). The mKR transgene was included as a lineage tracer for CNCC-derived cells that migrated
into the arches. (I,J) Skeletal staining at 5 dpf shows severe loss of craniofacial skeleton in sox10:Gal4VP16; UAS:Bmp4; UAS:mKR embryos (n=7/7)
compared to sox10:Gal4VP16; UAS:mKR controls (n=0/9). (K,L) In situs for foxd3 at 48 hpf reveal largely normal patterns of glia in sox10:Gal4VP16;
UAS:Bmp4; UAS:mKR embryos (n=8) and sox10:Gal4VP16; UAS:mKR controls (n=11). (M–P) In situs at 28 hpf show normal dct-positive melanophore
precursors in sox10:Gal4VP16; UAS:Bmp4; UAS:mKR embryos (n=12) and sox10:Gal4VP16; UAS:mKR controls (n=15) and normal xdh-positive
xanthophore precursors in sox10:Gal4VP16; UAS:Bmp4; UAS:mKR embryos (n=10) and sox10:Gal4VP16; UAS:mKR controls (n=10). Scale bars=50 mm.
doi:10.1371/journal.pgen.1002710.g008
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found no evidence for pigment cells, functional glia, or neurons
forming ectopically in Twist1-deficient arches. Hence, loss of
Twist1 function is not sufficient for arch CNCCs to generate non-
ectomesenchyme derivatives.
Twist1 promotes ectomesenchyme through both Fgf-
dependent and -independent gene activation
Our data also indicate that Twist1 promotes ectomesenchyme
fates through two largely parallel pathways. The finding that
Twist1 was required for expression of the Fgf target gene pea3 in
arch ectomesenchyme suggests a role for Twist1 in potentiating
Fgf signaling. Twist1 might do so by regulating expression of Fgf
ligands and/or receptors, as Twist1 has been shown to regulate
the CNCC expression of both Fgf10 and Fgfr1 in mice [12].
Hence, Twist1 could function upstream of autocrine/paracrine
Fgf signaling within CNCCs that promotes ectomesenchyme
development. However, although Fgf signaling was required to
repress sox10 and activate dlx2a expression, we found that fli1a
ectomesenchyme expression was Fgf-independent. Instead, fli1a
appears to be a potentially direct target of Twist1, and we have
identified a conserved ectomesenchyme enhancer element of
fli1a that is Twist1-dependent. However, chromatin immuno-
precipitation experiments (currently not feasible due to the lack
of a high quality Twist1 antibody) will eventually be needed to
show enhancer occupancy by Twist1. Moreover, the function of
Fli1a in ectomesenchyme formation also remains to be
investigated. Targeted disruption of the Fli1 gene in mouse
results in embryonic lethality by E12.5 due to severe hemor-
rhaging, thus precluding an analysis of its role in development of
the ectomesenchyme-derived craniofacial skeleton [45]. In the
future, the generation of zebrafish fli1a mutants and/or
conditional Fli1 mouse knockouts will allow us to determine
the extent to which Fli1 mediates that effects of Twist1 in
craniofacial development.
Id2a restricts Twist1 activity to the ectomesenchyme
The expression of Twist1 genes throughout early CNCCs in
both zebrafish [13] and mice [46,47] suggests that Twist1 function
is regulated at the post-translational level during ectomesenchyme
formation, either through enzymatic modifications or changes in
dimerization partners. Here we find evidence for the latter, with
the Bmp target gene Id2a functioning oppositely to Twist1 for
ectomesenchyme specification. Previous work suggests that Id2a
does not inhibit Twist1 function per se, but instead would
modulate what types of dimers Twist1 forms [14,15]. In the future,
the identification of binding partners for Twist1 in CNCCs will
allow us to test what roles Twist1 heterodimers versus homodimers
play in ectomesenchyme specification. Furthermore, we note that
Twist1 genes continue to be expressed in arch ectomesenchyme
and likely have additional roles in facial skeletal patterning, for
example by interacting with other bHLH factors such as Hand2
[48]. Hence, different Twist1 heterodimers may have distinct roles
during craniofacial development (i.e. ectomesenchyme formation
versus arch patterning), with the later disruption of these
heterodimers in Twist1-deficient and Id2a-misexpression embryos
also contributing to some aspects of the observed facial skeletal
defects.
Figure 9. Mesoderm and endoderm are not essential for ectomesenchyme formation. (A–D) In situs at 12 hpf show loss of axial ntl and
mesodermal myod expression in Antivin-mRNA-injected embryos compared to un-injected controls. (E,F) Confocal projections of her5:GFP expression
at 19 hpf show loss of pouch endoderm (arrows) but not brain (arrowheads) in Antivin-mRNA-injected embryos compared to un-injected controls.
(G,H) In situs at 15.5 hpf show normal ectomesenchyme induction of dlx2a in Antivin-mRNA-injected embryos (n=12) and un-injected controls
(n=13). Arches are numbered. (I,J) Double fluorescent in situs at 15.5 hpf show normal induction of dlx2a (green) in sox10-positive CNCCs (red, yellow
indicates co-localization) in Antivin-mRNA-injected embryos (n=15) and un-injected controls (n=9). (K,L) Double fluorescent in situs at 19 hpf show
complementary expression of fli1a (green) in ectomesenchyme and sox10 (red) in non-ectomesenchyme in Antivin-mRNA-injected embryos (n=5)
and un-injected controls (n=8). Scale bar=50 mm.
doi:10.1371/journal.pgen.1002710.g009
Bmps Inhibit Ectomesenchyme
PLoS Genetics | www.plosgenetics.org 11 May 2012 | Volume 8 | Issue 5 | e1002710A Bmp-dependent switch for ectomesenchyme
formation
Previous studies have shown both temporal and spatial
components to the specification of the large diversity of neural
crest derivatives. In the trunk, neural crest cell fate is influenced
both by migration pathways [49,50] and signals at their
destinations [51]. In contrast, CNCCs appear to be largely fate-
restricted before migration in zebrafish, with Wnts from the dorsal
ectoderm promoting pigment at the expense of neural and glial
fates but having little effect on ectomesenchyme derivatives [4,5].
Instead, we find that Bmps, also from the ectoderm, actively
inhibit ectomesenchyme fates in more dorsal CNCCs. Further-
more, this observed role of Bmps in regulating ectomesenchyme
specification is not simply an indirect effect of earlier roles of Bmps
Figure 11. Model of ectomesenchyme specification. At 12 hpf, Bmps in the neural plate border ectoderm promote moderate expression of
id2a in multipotent CNCCs. As ectomesenchyme precursors delaminate from the neuroepithelium and migrate away from the Bmp source (16 hpf),
they downregulate id2a expression, which allows Twist1 to induce fli1a expression and potentiate Fgf signaling. Fgf signaling then inhibits sox10 and
promotes dlx2a expression. In the non-ectomesenchyme, sustained Bmp activity and id2a expression dampens Twist1-dependent inhibition of
neural, glia, and pigment gene expression programs. Lateral diagrams are shown on the left and cross-sectional diagrams on the right.
doi:10.1371/journal.pgen.1002710.g011
Figure 10. Reduction of Id2a rescues the ectomesenchyme defects caused by Bmp4 misexpression. (A–L) Colorimetric in situs show
ectopic sox10 arch expression at 18 hpf and reductions of dlx2a and fli1a arch expression at 24 hpf in sox10:Gal4VP16; UAS:Bmp4 embryos but not
sox10:Gal4VP16 control or id2a-MO-injected embryos. sox10:Gal4VP16; UAS:Bmp4 embryos injected with id2a-MO showed complete rescue of sox10
and dlx2a expression and partial rescue of fli1a expression. Arches are numbered and arrows denote the second arch, white arrowheads the
developing ear, and red arrowheads the vasculature. Scale bar=50 mm. (M–O) Quantification of gene expression defects. The mutant index is based
on the following: 0=normal, 1=partially defective, 2=fully defective. Fully defective was defined as gene expression being of equal intensity to that
seen in un-injected sox10:Gal4VP16; UAS:Bmp4 embryos. For sox10, partially defective was defined as a reduction in the number of expressing cells
and/or the intensity of arch expression compared to un-injected sox10:Gal4VP16; UAS:Bmp4 embryos. For fli1a and dlx2a, partially defective was
defined as a level of arch expression intermediate between un-injected sox10:Gal4VP16; UAS:Bmp4 and sox10:Gal4VP16 control embryos. The rescue
of Bmp4 misexpression defects with id2a-MO injection was statistically significant for all genes based on a Tukey-Kramer HSD test (a=0.05). Standard
errors of the mean are shown.
doi:10.1371/journal.pgen.1002710.g010
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result in decreased amounts of CNCC being generated or defects
in non-ectomesenchyme derivatives
The down-regulation of Bmp activity in ectomesenchyme
precursors could reflect CNCCs distancing themselves from a
Bmp source in the non-neural ectoderm (e.g. Bmp2b) and/or
active inhibition of Bmp signaling during migration. Whereas the
Bmp antagonist Noggin1 is expressed in the paraxial mesoderm
surrounding migratory CNCCs in zebrafish [52], genetic ablation
of endoderm and mesoderm did not disrupt ectomesenchyme gene
expression, although there are likely other sources of Bmp
inhibitors [53]. Alternatively, the down-regulation of Bmp activity
could result from the delamination of CNCCs from the neural
plate ectoderm, with the basement membrane of the ectodermal
epithelium, under which CNCCs migrate, serving as a barrier to
apical Bmp secretion and signaling [54].
Although we found that Bmp down-regulation was essential for
ectomesenchyme formation, transgenic inhibition of Bmp (or Id2a
depletion) did not result in ectopic ectomesenchyme (data not shown).
Therefore,low Bmp activityis not sufficient to specifyectomesenchyme
fates.Instead,Bmp down-regulation might allow CNCCsto respond to
ectomesenchyme-promoting signals present only in the early CNCC
milieu. In particular, our data suggest that activation of Twist1 at low
Bmp levels allows migrating CNCCs to respond to Fgfs. Although the
exact source of Fgfs remains to be determined, we propose that a
combination of low Bmp and high Fgf signaling uniquely present in
early migrating CNCCs generates ectomesenchyme fates.
Materials and Methods
Ethics statement
All animals were handled in strict accordance with good animal
practice as defined by the relevant national and/or local animal
welfare bodies, and all animal work was approved by the
University of Southern California Institutional Animal Care and
Use Committee.
Zebrafish lines and transgenic constructs
Zebrafish were staged as described [55]. Previously reported lines
include Tg(hsp70I:Gal4)
kca4 [56], Tg(,3.4her5:EGFP)
ne1911 [57],
and Tg(UAS:Bmp4; cmlc2:GFP)
el49 [53]. Tg(sox10:Gal4VP16)
el159,
Tg(UAS:mKR; cmlc2:GFP)
el15, Tg(UAS:kikGR; a-crystallin:Cerulean)
el377,
Tg(UAS:Id2a;a-crystallin:Cerulean)
el405,Tg(UAS:dnFgfr1a;cmlc2:GFP)
el28,
Tg(UAS:dnTwist1b; UAS:mcherryCAAX; cmlc2:GFP)
el179, Tg(sox10:dsRE-
D)
el10, Tg (sox10:LOX-GFP-LOX-hDLX3)
el8,a n dTg(fli1a-F-hsp70I:GF-
P)
el411 lines were generated using Gateway cloning (Invitrogen) and
the Tol2 kit as described [58]. sox10:Gal4VP16 was created by
combining p5E-sox10, pME-Gal4VP16, p3E-IRES-GFP-pA, and
pDestTol2pA2.The IRES-GFPwaslaterfoundtobenon-functional
in stable transgenics. UAS:mKR, UAS:kikGR, and UAS:dnFgfr1a
were generated by combining p5E-UAS;p M E - m K R ,p M E - k i k G R ,
or pME-dnFgfr1a; p3E-polyA; and pDestTol2CG2. UAS:dnTwist1b
was made by combining p5E-UAS, pME-dnTwist1b, p3E-UAS:m-
CherryCAAXpA, and pDestTol2CG2. The dnTwist1b clone was
made by first amplifying the full-length zebrafish twist1b cDNA with
primers rTwist1bikL: 59-GGGGACAAGTTTGTACAAAAAAG-
CAGGCTCGGCCACCATGCCCGAAGAGCCCGCGGAGA-
39 and Twrk: 59-GGGGACCACTTTGTACAAGAAAGCTGGG-
TACTTAGATGCAGACATGGACCAAGCGCC-39. PCR based
mutagenesis was then performed with primers twdnEK1L: 59-
GCGCTTTCGCAGAGACTTA-39 and twdnEK1R 59-CTGT-
CGCTTGCGCACGTT-39 as described [59] to change nucleotide
G250 of the twist1b cDNA to A, which results in conversion of amino
acid 84E to K, with the PCR product cloned into pDONR221 to
createpME-dnTwist1b.ToconstructpME-dnFgfr1a,weamplifieda
truncated form of zebrafish fgfr1a based on the previously reported
dominant-negative Fgf receptor in Xenopus laevis [60] and cloned
the PCR product into pDONR221; primers used were 59-GG-
GGACAAGTTTGTACAAAAAAGCAGGCTCCACCATGAT-
AATGAAGACCACGCTG-39 and 59GGGGACCACTTTGTA-
CAAGAAAGCTGGGTCTAAGAGCTGTGCATTTTGGC-39.
Full-length zebrafish id2a was amplified with primers id2a-F: 59-
GGGGACAAGTTTGTACAAAAAAGCAGGCTCGGCCACC-
ATGAAGGCAATAAG-39and id2a-R:59-GGGGACCACTTTG-
TACAAGAAAGCTGGGTGTTAACGGTAAAGTGTCCT-39
and then cloned into pDONR221 to generate pME-Id2a. UAS:Id2a
was generated by combining p5E-UAS, pME-Id2a, p3E-polyA, and
pDestTol2AB2. sox10:dsRED and sox10:LOX-GFP-LOX-Dlx3
were generated by combining p5E-sox10, p3E-polyA, and pDest-
Tol2pA2 with either pME-dsRed or pME-LOX-GFP-LOX-Dlx3,
respectively. UAS:mKR was made by combining p5E-UAS,p M E -
mKR, p3E-polyA, and pDestTol2CG2. pME-mKR was made by
PCR amplification of membraneKillerRed (mKR) with primers
kilredL: 59-GGGGACAAGTTTGTACAAAAAAGCAGGCTCG-
GTCGCCACCATGCTGTG-39 and kilredR: 59-GGGGAC-
CACTTTGTACAAGAAAGCTGGGTTTAATCCTCGTCG-
CTACCGA-39 and insertion into pDONR221. UAS:kikGR was
made by combining p5E-UAS,p M E - k i k G R ,p 3 E - p o l y A ,a n d
pDestTol2AB2. fli1a enhancers were amplified with the following
primer sets from zebrafish genomic DNA and cloned into the
pDONR-p4p1R vector: (G) Fli-2: 59-GGGGACAACTTTGTA-
TAGAAAAGTTGTAGAGCGTGCTCGGTAACTG-39 and Fli-
3: 59-GGGGACTGCTTTTTTGTACAAACTTGGAGCCCGA-
CAATATTCCAAA-39, (B–F) Fli-6: 59-GGGGACAACTTTGTA-
TAGAAAAGTTGTTGCACTGGGCAAACTTTAG-39 and Fli-
15: 59-GGGGACTGCTTTTTTGTACAAACTTGCTCTAGA-
CGCTCAGCCAACC-39,( B – D )F l i - 6a n dF l i - 1 3 :5 9-GGGG-
ACTGCTTTTTTGTACAAACTTGAGGCTGTCCTGACT-
GCTGAT-39, (E–F) Fli-14: 59-GGGGACAACTTTGTATAGA-
AAAGTTGAGCACTTCAGGGTTTTTCCA-39 and Fli-15, (E)
Fli-14 and Fli-18: 59-GGGGACTGCTTTTTTGTACAAACTT-
GATTGCGTCCAGTTAGATCGG-39,( F )F l i - 1 9 :5 9-GGGGA-
CAACTTTGTATAGAAAAGTTGATGTTGCATCACTTTT-
CCCC-39 and Fli-15, and (H) Fli-16: 59-GGGGACAACTTTG-
TATAGAAAAGTTGATGGTTTGTTGCAGTCGGTT-39 and
Fli-17: 59-GGGGACTGCTTTTTTGTACAAACTTGCGCAG-
GATTACGCTGGAATA-39. pME-hsp70I:GFP was constructed
by fusion PCR of the hsp70I promoter and full-length GFP. PCR-
based mutagenesis of the fli1a-F enhancer was performed using
primers: 59-GTATACTGGGGCTCTCGAGG-39 and 59-CTAG-
CAGGATCGTATACTGGG-39. p5E enhancer vectors were then
combined with pME-hsp70I:GFP, p3E-polyA, and pDestTol2pA2.
To construct stable transgenics, one-cell-stage embryos were injected
with vectors and transposase RNA and multiple stable lines were
identified for each transgene: Tg(sox10:Gal4VP16) (1), Tg(UAS:Id2a;
a-crystallin:Cerulean) (5), Tg(UAS:dnTwist1b; UAS:mcherryCAAX; cmlc2:
GFP) (7), Tg(UAS:dnFgfr1a; cmlc2:GFP) (6), Tg(UAS:mKR; cmlc2:GFP)
(2),Tg(UAS:kikGR;cmlc2:GFP)(3),Tg(sox10:dsRED)(1),Tg(sox10:LOX-
GFP-LOX-hDLX3) (2), and Tg(fli1-F-hsp70I:GFP) (2). In the absence
of CRE, Tg(sox10:LOX-GFP-LOX-hDLX3)
el8 (referred to as sox10:
GFP in the Results) drives similar GFP expression as the previously
reported Tg(,4725sox10:GFP)
ba2 line but without neural crest cell
toxicity [25]. For sox10:Gal4VP16/UAS:transgene experiments,
genotyping for Gal4 and cmlc2 [61] confirmed the observed pheno-
types, except for sox10:Gal4VP16/UAS:Id2a experiments where
genotyping for Id2a was performed with primers id2aF: 59-
AGAACACCCCTGACAACACT-39 and id2aR: 59-G C T A A -
TACGACTCACTATAGGTACCGGCAGTCCAATTTC-39.
Bmps Inhibit Ectomesenchyme
PLoS Genetics | www.plosgenetics.org 13 May 2012 | Volume 8 | Issue 5 | e1002710In situ hybridization, immunohistochemistry, and skeletal
analysis
Alcian Blue staining of cartilage and Alizarin Red staining of
bone at 5 dpf, as well as in situ hybridizations, were performed as
described [61]. Reported probes include sox9a and sox9b [62],
tfap2a [63], and fli1a [9]. id2a, sox10, fli1a, twist1a, ntla, dct, xdh, pea3,
kikGR, mKR, gch2, nr4a2b, and foxd3 probes were synthesized with
T7 RNA polymerase from PCR products amplified from
multistage zebrafish cDNA, with the exception of id2a which
was amplified from an id2a cDNA plasmid (Zebrafish Interna-
tional Resource Center). We used the following primer pairs: id2a:
id2aF and id2aR, twist1a:5 9-CAGAGTCTCCGGTGGACAGT-
39 and 59-GCTAATACGACTCACTATAGGGTCTTTTCCT-
GCAGCGAGTC-39, ntla:5 9- GACCACAAGGAAGTCCCA-
GA-39 and 59- GCTAATACGACTCACTATAGGCATTGAG-
GAGGGAGAGGACA-39, dct:5 9- CGTACTGGAACTTTGC-
GACA-39 and 59-GCTAATACGACTCACTATAGGACCAA-
CACGATCAACAGCAG-39, xdh:5 9-TGAACACTCTGACG-
CACCTC-39 and 59-GCTAATACGACTCACTATAGGTGTT-
GAAGCTCCAGCAACAC-39, foxd3:5 9-CGGCATTGGGAA-
TCCATA-39 and 59-GCTAATACGACTCACTATAGGCAAC-
GAAATGAAATAGAAAGAAGGA-39, pea3:5 9-CCCATATGA-
TGGTCAAACAGG-39 and 59- GCTAATACGACTCACTA-
TAGGATTGTCGGGAAAAGCCAAG-39, kikGR:5 9-GAAGAT-
CGAGCTGAGGATGG-39 and 59- GCTAATACGACTCAC-
TATAGGGCTCGTACAGCTTCACCTTGT-39, mkr:5 9-GGG-
CAGAAGTTCACCATCG-39 and 59-GCTAATACGACTCAC-
TATAGGGTGGTGAAGCCGATGAAGG-39, nr4a2b:5 9-CCA-
GGCTCAGTATGGGACAT-39 and 59-GCTAATACGACTC-
ACTATAGGTATGTGACGTCGCCAGGTAG-39, sox10:5 9-
TGCATTACAAGAGCCTGCAC-39 and 59- GCTAATACG-
ACTCACTATAGGAGGAGAAGGCGGAGTAGAGG-39, and
gch2:5 9- GGAATACCAAAAGGCAGCAG-39 and 59-GCTAA-
TACGACTCACTATAGGCTCTCTGAACACACCCAGCA-39.
Immunostaining was performed as described [53] using the
following antibodies: rabbit anti-pSMAD1/5/8 (Cell Signaling,
#9511S, 1:1000), goat anti-rabbit Alexa-568 (Molecular Probes,
1:1000), mouse anti-HuC/D (1:100; Molecular Probes), and goat
anti-mouse Alexa-488 (Molecular Probes 1:1000). Cell death
assays with Lysotracker Red were performed as described [53].
Morpholino and mRNA injections
One-cell-stage embryos were injected with 3 nl of the following
translation-blocking MOs (GeneTools, Philomath, OR, USA):
twist1a-MO 59- ACCTCTGGAAAAGCTCAGATTGCGG-39
(400 mM), twist1b–MO 59-TTAAGTCTCTGCTGAAAGCGC-
GTG-39 (400 mM), twist1a/1b-MO (200/200 mM), and id2a-MO
59-GCCTTCATGTTGACAGCAGGATTTC-39 (800 mM) [17].
For MO validation, we performed rescue experiments with in vitro
transcribed mRNA generated using the Ambion Message machine
kit (Applied Biosystems) from a CMV/SP6-Twist1b template
generated by combining p5E-CMV/SP6, pME-Twist1b, p3E-
polyA, and pDestTol2pA2. Antivin mRNA was synthesized and
injected as described [40].
Imaging
Larval skeletons and colorimetric in situ hybridization
embryos were imaged using a Leica MZ16F dissecting
microscope using Camera Window software for a Canon60
Shot 80S digital camera. Fluorescent images were captured
using a Zeiss LSM5 confocal microscope with Zen software.
Identical gain settings were used to acquire fluorescent in situ
images across data sets. Images were processed using Photoshop
CS4 with care taken to apply identical adjustments throughout
data sets.
Microarray analysis
sox10:GFP embryos were injected with twist1a/1b-MO. Con-
trol and injected embryos were sorted for GFP under a
fluorescent dissecting microscope and samples were prepared
for FACS using the ‘‘cell disruption for flow sorting’’ protocol
described previously [64]. A BD Aria Sorter was used to isolate
equal numbers of GFP-positive and GFP-negative cells and RNA
was isolated using Trizol (Invitrogen). cDNA was then generated
using the WTA2 kit (Sigma Aldrich) and hybridized to a 385K
zebrafish array (Roche #05543916001). Microarray data were
normalized by Nimblegen, and processed data files were analyzed
using Arraystar 4.0 software (DNAstar). Three independent
experiments were performed, and a cut-off value of p,0.05 was
used for significance. All data was submitted to GEO (Accession
#GSE32308).
Luciferase assay
The Twist1 expression vector was made by cloning the
zebrafish twist1b cDNA into pCDNA3. Luciferase reporter
constructs were generated by cloning wild-type and mutant
versions of the fli1a-F enhancer into the Pgl3 basic vector
(Progema #E1715). We then transfected 293T cells with the
Twist1b expression and luciferase reporter plasmids and used the
Dual Luciferase Assay kit (Promega #E1910) per manufacturer
instructions to measure firefly luciferase activity relative to renilla
luciferase activity 48 hours after transfection. All experiments were
performed in triplicate.
Statistical analysis
Statistics were performed with JMP7 software. One-way analysis
of variance was calculated with a Tukey-Kramer HSD test
(alpha=0.05) and standard errors of the mean were plotted.
Supporting Information
Figure S1 Twist1a and Twist1b function redundantly to specify
ectomesenchyme. (A–C) In situs at 18 hpf show sox10 expression in
un-injected, twist1a-MO, and twist1b-MO embryos. A few ectopic
sox10-positive cells are seen in the second arches (arrows) of twist1a-
MO and twist1b-MO embryos. White arrowheads denote the
developing ear. (D–G) Confocal projections of fli1a:GFP;
sox10:dsRed doubly transgenic embryos at 28 hpf show normal
fli1a:GFP expression in un-injected control, twist1a-MO, and
twist1b-MO embryos and loss of fli1a:GFP arch expression in
twist1a/1b-MO embryos. Arrows indicate fli1a:GFP vascular
expression which is unaffected in twist1a/1b-MO embryos. (H–L)
Skeletal staining shows malformed mandibular and hyoid skeletons
in twist1a-MO and twist1b-MO embryos compared to un-injected
controls. In addition, co-injection of a Twist1b mRNA not targeted
by the MOs partially rescued the head skeleton of twist1a/1b-MO
embryos (n=24/24), whereas co-injection of a control kikGR
mRNA never rescued (n=0/11). Scale bars=50 mm.
(TIF)
Figure S2 Time-course of sox10:Gal4VP16-dependent trans-
gene expression. (A–D) In situs for kikGR mRNA in sox10:-
Gal4VP16; UAS:kikGR embryos show transgene expression
in migratory CNCCs at 13 hpf but not in pre-migratory
CNCCs at 11 hpf. sox10:Gal4VP16 control embryos show no
expression.
(TIF)
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1b-MO and Id2a misexpression embryos. (A–D) Confocal
projections of anti-HuC/D immunofluorescence show neurons
of the trigeminal (tg), anterior lateral line (all), otic (ot), and
posterior lateral line (pll) ganglia at 36 hpf. No major differences in
the pattern of anti-HuC/D staining was observed between
uninjected control (n=6), twist1a/1b-MO (n=6), sox10:Gal4VP16
only control (n=9), and sox10:Gal4VP16: UAS:Id2a (n=8)
embryos. Scale bar=50 mm.
(TIF)
Figure S4 Cell death and sox9a expression in twist1a/1b-MO
embryos. (A–D) Confocal projections of Lysotracker Red
staining in 36 hpf sox10:GFP transgenic embryos show increased
cell death in the pharyngeal arches (shown in high-magnification
views in C and D from the boxes in A and B) in twist1a/1b-MO-
injected embryos (n=6) compared to un-injected controls (n=6).
Arrowhead shows increased cell death in more dorsal CNCCs as
well. Scale bar=50 mm. (E) Quantification of Lysotracker-
positive cells per arch area. Mandibular and hyoid arches were
used for the analysis. Asterisk indicates statistical significance
using a Tukey-Kramer HSD test (a=0.05). (F,G) In situ
hybridizations for sox9a at 48 hpf show very reduced expression
in the pharyngeal arches of twist1a/1b-MO embryos (n=5/5)
compared to uninjected controls (n=0/12). Dorsal (D) and
ventral (V) pre-chondrogenic domains of the mandibular (1) and
hyoid (2) arches are shown for the control. sox9a expression in
the pre-chondrogenic domain of the mesoderm-derived otic
capsule cartilage (arrows) was less affected in twist1a/1b-MO
embryos.
(TIF)
Figure S5 Induction and early migration of CNCCs is
unaffected by Bmp4 misexpression. In situs for sox10 at 15 hpf
show no difference in early migrating CNCCs between sox10:
Gal4VP16; UAS:Bmp4 embryos (n=5) and sox10:Gal4VP16 only
controls (n=12). Scale bar=50 mm.
(TIF)
Figure S6 Cell death analysis in sox10:Gal4VP16; UAS:Bmp4
embryos. Compared to sox10:Gal4VP16 only controls (n=8),
Lysotracker staining reveals no major increase in cell death at 24 hpf
in sox10:Gal4VP16; UAS:Bmp4 embryos (n=8). Scale bar=50 mm.
(TIF)
Figure S7
Injection of twist1b mRNA fails to rescue sox10 ectomesenchyme
persistence in Bmp4 misexpression embryos. (A–C) sox10 expres-
sion at 18 hpf was similarly upregulated in the arches of uninjected
sox10:Gal4VP16; UAS:Bmp4 embryos (n=11/11) and twist1b-
mRNA-injected sox10:Gal4VP16; UAS:Bmp4 embryos (n=5/5)
compared to sox10:Gal4VP16 only controls (n=0/10). Scale
bar=50 mm.
Table S1 Summary of CNCC genes affected by Twist1
depletion in the microarray analysis.
(XLS)
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